PLAN TO FURTHER MINIMIZE THE USE OF HIGHLY ENRICHED URANIUM FOR MEDICAL ISOTOPES.

SEC. 3143. PLAN TO FURTHER MINIMIZE THE USE OF HIGHLY ENRICHED URANIUM FOR MEDICAL ISOTOPES. (a) Plan.—The Secretary of Energy, in consultation with the Secretary of State, shall develop and assess a plan, including with respect to the benefits, risks, costs, and opportunities of the plan, to— (1) take additional actions to promote the wider utilization of molybdenum-99 and technetium-99m produced without the use of highly enriched uranium targets, such as, at a minimum, by— (A) eliminating the availability of highly enriched uranium for molybdenum-99 by buying back United States-origin highly enriched uranium in raw or target form from global molybdenum-99 suppliers; and (B) restricting or placing financial penalties on the import of molybdenum-99 produced with highly enriched uranium targets; (2) work with global molybdenum suppliers and regulators to reduce the proliferation hazard from reprocessing waste from medical isotope production containing United States-origin highly enriched uranium; and (3) ensure an adequate supply of molybdenum-99 and technetium-99 at all times, and both assess and mitigate any risks to such supply during a transition to production without the use of highly enriched uranium. (b) Submission.— (1) In general.—Not later than April 1, 2018, the Secretary of Energy shall submit to the appropriate congressional committees a report containing the plan and assessment under subsection (a). (2) Form.—The report under paragraph (1) shall be submitted in unclassified form, but may include a classified annex. (3) Appropriate congressional committees defined.—In this subsection, the term “appropriate congressional committees” means— (A) the congressional defense committees; (B) the Committee on Foreign Affairs and the Committee on Energy and Commerce of the House of Representatives; and (C) the Committee on Foreign Relations and the Committee on Energy and Natural Resources of the Senate.